New 2021 Forecasts Released

New Data
innovation hub

Foundation Medicine (NASDAQ: FMI) (Acquired) is Profiled in this Database

Updated At 27 Jan, 2012

Start Free 7 Day Trial Now
Partial description of this company
A molecular diagnostics test that examines somatic alterations in cancer-related genes by applying massively parallel sequencing to routine clinical specimens, enabling targeted therapy

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Foundation Medicine (NASDAQ: FMI) (Acquired) plus 4810 other startups.

Start Free 7 Day Trial Now

Learn More About Foundation Medicine (NASDAQ: FMI) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

More

Our Clients